Neurological Complications at Stroke Patients With Diabetes Mellitus (SDM)

This study has been completed.
Sponsor:
Information provided by:
Evangelisches Krankenhaus Bielefeld gGmbH
ClinicalTrials.gov Identifier:
NCT01172977
First received: July 28, 2010
Last updated: June 21, 2011
Last verified: June 2011

July 28, 2010
June 21, 2011
August 2010
March 2011   (final data collection date for primary outcome measure)
Functional outcome six months after the cerebral ischemia [ Time Frame: six months ] [ Designated as safety issue: No ]
Functional outcome for the National Institutes of Health Stroke scale, the Barthel Index and Modified Ranking Scala six months after the cerebral ischemia.
Same as current
Complete list of historical versions of study NCT01172977 on ClinicalTrials.gov Archive Site
  • Additional cerebral ischemia [ Time Frame: six months ] [ Designated as safety issue: No ]
    Additional cerebral ischemia six months after the first cerebral ischemia
  • Mortality [ Time Frame: sixt months ] [ Designated as safety issue: No ]
    Mortality in the first 6 months after the primary cerebral ischemia
Same as current
Not Provided
Not Provided
 
Neurological Complications at Stroke Patients With Diabetes Mellitus
Neurological Complications at Stroke Patients With Diabetes Mellitus During the First Six Months After a Cerebral Ischemia

It is to be investigated if a correlation exist between the development of the HbA1c value and the complication rate is following a stroke.

The immediate objective of the study is to find out if a correlation between blood sugar control in diabetics and the incidence of complications after a stroke exists.

The study has a high practical importance because any consequences in the treatment of diabetes mellitus can be implemented without affecting costs.

Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Stroke patients on the Stroke Unit with hyperglycemia with cerebral ischemia within the last 24 hours

  • Stroke
  • Diabetes Mellitus
Not Provided
  • HbA1c ≤ 7
    Stroke patients with mild diabetes mellitus HbA1c ≤ 7
  • HbA1c ≥ 7,5
    Stroke patients with severe diabetes mellitus HbA1c ≥ 7,5
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
March 2011
March 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Stroke patients on the Stroke Unit with hyperglycemia with cerebral ischemia within the last 24 hours

Exclusion Criteria:

  • Patients with intracerebral hemorrhage
  • Pregnant patients
  • Patients with sensory aphasia
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01172977
EvKB Barzu, DRKS00000470
Yes
Barzu Cristian
Evangelisches Krankenhaus Bielefeld gGmbH
Not Provided
Principal Investigator: Cristian Barzu, MD Evangelisches Krankenhaus Bielefeld, Germany
Evangelisches Krankenhaus Bielefeld gGmbH
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP